Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases (original) (raw)

• Danial, N. N. & Korsmeyer, S. J. Cell death: critical control points. Cell 116, 205–219 (2004).
  Article CAS PubMed Google Scholar
• Corral-Debrinski, M. et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet. 2, 324–329 (1992).
  CAS PubMed Google Scholar
• Zhang, J. et al. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc. Natl Acad. Sci. USA 100, 1116–1121 (2003).
  ADS CAS PubMed PubMed Central Google Scholar
• Chinnery, P. F. et al. Point mutations of the mtDNA control region in normal and neurodegenerative human brains. Am. J. Hum. Genet. 68, 529–532 (2001).
  CAS PubMed Google Scholar
• Simon, D. K. et al. Low mutational burden of individual acquired mitochondrial DNA mutations in brain. Genomics 73, 113–116 (2001).
  CAS PubMed Google Scholar
• Lin, M. T., Simon, D. K., Ahn, C. H., Kim, L. M. & Beal, M. F. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum. Mol. Genet. 11, 133–145 (2002).
  CAS PubMed Google Scholar
• Jazin, E. E., Cavelier, L., Eriksson, I., Oreland, L. & Gyllensten, U. Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc. Natl Acad. Sci. USA 93, 12382–12387 (1996).
  ADS CAS PubMed PubMed Central Google Scholar
• Bender, A. et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nature Genet. 38, 515–517 (2006).
  MathSciNet CAS PubMed Google Scholar
• Kraytsberg, Y. et al. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nature Genet. 38, 518–520 (2006).
  CAS PubMed Google Scholar
• Trifunovic, A. Mitochondrial DNA and ageing. Biochim. Biophys. Acta 1757, 611–617 (2006).
  CAS PubMed Google Scholar
• Andreyev, A. Y., Kushnareva, Y. E. & Starkov, A. A. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc.) 70, 200–214 (2005).
  CAS Google Scholar
• Sun, J., Folk, D., Bradley, T. J. & Tower, J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 161, 661–672 (2002).
  CAS PubMed PubMed Central Google Scholar
• Ruan, H. et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc. Natl Acad. Sci. USA 99, 2748–2753 (2002).
  ADS CAS PubMed PubMed Central Google Scholar
• Schriner, S. E. et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909–1911 (2005).
  ADS CAS PubMed Google Scholar
• Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883–891 (2004).
  ADS CAS PubMed Google Scholar
• Nunomura, A. et al. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759–767 (2001).
  CAS PubMed Google Scholar
• Pratico, D., Uryu, K., Leight, S., Trojanoswki, J. Q. & Lee, V. M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21, 4183–4187 (2001).
  CAS PubMed PubMed Central Google Scholar
• Reddy, P. H. et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum. Mol. Genet. 13, 1225–1240 (2004).
  CAS PubMed Google Scholar
• Ohyagi, Y. et al. Selective increase in cellular A β 42 is related to apoptosis but not necrosis. Neuroreport 11, 167–171 (2000).
  CAS PubMed Google Scholar
• Busciglio, J. et al. Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33, 677–688 (2002).
  CAS PubMed Google Scholar
• Li, F. et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89, 1308–1312 (2004).
  CAS PubMed Google Scholar
• Velliquette, R. A., O'Connor, T. & Vassar, R. Energy inhibition elevates β-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci. 25, 10874–10883 (2005).
  CAS PubMed PubMed Central Google Scholar
• Tamagno, E. et al. β-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628–636 (2005).
  CAS PubMed Google Scholar
• Lovell, M. A., Xiong, S., Xie, C., Davies, P. & Markesbery, W. R. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J. Alzheimers Dis. 6, 659–671 (2004).
  CAS PubMed Google Scholar
• Sultana, R. et al. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis. Neurobiol. Aging 27, 918–925 (2006).
  CAS PubMed Google Scholar
• Pastorino, L. et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 440, 528–534 (2006).
  ADS CAS PubMed Google Scholar
• Liou, Y. C. et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424, 556–561 (2003).
  ADS CAS PubMed Google Scholar
• Swerdlow, R. H. et al. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology 49, 918–925 (1997).
  CAS PubMed Google Scholar
• Elson, J. L. et al. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease? Hum. Genet. 119, 241–254 (2006).
  CAS PubMed Google Scholar
• Coskun, P. E., Beal, M. F. & Wallace, D. C. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc. Natl Acad. Sci. USA 101, 10726–10731 (2004).
  ADS CAS PubMed PubMed Central Google Scholar
• Anandatheerthavarada, H. K., Biswas, G., Robin, M. A. & Avadhani, N. G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161, 41–54 (2003).
  CAS PubMed PubMed Central Google Scholar
• Lustbader, J. W. et al. ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 304, 448–452 (2004).
  ADS CAS PubMed Google Scholar
• Crouch, P. J. et al. Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42 . J. Neurosci. 25, 672–679 (2005).
  CAS PubMed PubMed Central Google Scholar
• Manczak, M. et al. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437–1449 (2006).
  CAS PubMed Google Scholar
• Casley, C. S., Canevari, L., Land, J. M., Clark, J. B. & Sharpe, M. A. β-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80, 91–100 (2002).
  CAS PubMed Google Scholar
• Gibson, G. E. et al. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 45, 836–840 (1988).
  CAS PubMed Google Scholar
• Parker, W. D., Filley, C. M. & Parks, J. K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302–1303 (1990).
  PubMed Google Scholar
• Park, H. J., Seong, Y. M., Choi, J. Y., Kang, S. & Rhim, H. Alzheimer's disease-associated amyloid β interacts with the human serine protease HtrA2/Omi. Neurosci. Lett. 357, 63–67 (2004).
  CAS PubMed Google Scholar
• Hansson, C. A. et al. Nicastrin, presenilin, APH-1, and PEN-2 form active γ-secretase complexes in mitochondria. J. Biol. Chem. 279, 51654–51660 (2004).
  CAS PubMed Google Scholar
• Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neurosci. 3, 1301–1306 (2000).
  CAS PubMed Google Scholar
• Fornai, F. et al. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin–proteasome system and α-synuclein. Proc. Natl Acad. Sci. USA 102, 3413–3418 (2005).
  ADS CAS PubMed PubMed Central Google Scholar
• Sherer, T. B. et al. Mechanism of toxicity in rotenone models of Parkinson's disease. J. Neurosci. 23, 10756–10764 (2003).
  CAS PubMed PubMed Central Google Scholar
• Schapira, A. H. et al. Mitochondrial complex I deficiency in Parkinson's disease. Lancet i, 1269 (1989).
  Google Scholar
• Simon, D. K. et al. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53, 1787–1793 (1999).
  CAS PubMed Google Scholar
• Luoma, P. et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364, 875–882 (2004).
  CAS PubMed Google Scholar
• Vives-Bauza, C. et al. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem. Biophys. Res. Commun. 290, 1593–1601 (2002).
  CAS PubMed Google Scholar
• Simon, D. K. et al. Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease. Neurobiol. Aging 25, 71–81 (2004).
  CAS PubMed Google Scholar
• Pyle, A. et al. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann. Neurol. 57, 564–567 (2005).
  PubMed Google Scholar
• Tanaka, M. Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease. J. Neurol. 249 (Suppl. 2), II11–II18 (2002).
  PubMed Google Scholar
• Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407 (2005).
  CAS PubMed PubMed Central Google Scholar
• Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E. & Masliah, E. Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186, 158–172 (2004).
  CAS PubMed Google Scholar
• Martin, L. J. et al. Parkinson's disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26, 41–50 (2006).
  CAS PubMed PubMed Central Google Scholar
• Klivenyi, P. et al. Mice lacking α-synuclein are resistant to mitochondrial toxins. Neurobiol. Dis. 21, 541–548 (2006).
  CAS PubMed Google Scholar
• Pesah, Y. et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131, 2183–2194 (2004).
  CAS PubMed Google Scholar
• Palacino, J. J. et al. Mitochondrial dysfunction and oxidative damage in _parkin_-deficient mice. J. Biol. Chem. 279, 18614–18622 (2004).
  CAS PubMed Google Scholar
• Muftuoglu, M. et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord. 19, 544–548 (2004).
  PubMed Google Scholar
• Darios, F. et al. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12, 517–526 (2003).
  ADS CAS PubMed Google Scholar
• Kuroda, Y. et al. Parkin enhances mitochondrial biogenesis in proliferating cells. Hum. Mol. Genet. 15, 883–895 (2006).
  CAS PubMed Google Scholar
• Chung, K. K. et al. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328–1331 (2004).
  ADS CAS PubMed Google Scholar
• Whitworth, A. J. et al. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc. Natl Acad. Sci. USA 102, 8024–8029 (2005).
  ADS CAS PubMed PubMed Central Google Scholar
• Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259 (2003).
  ADS CAS PubMed Google Scholar
• Meulener, M. C. et al. DJ-1 is present in a large molecular complex in human brain tissue and interacts with α-synuclein. J. Neurochem. 93, 1524–1532 (2005).
  CAS PubMed Google Scholar
• Moore, D. J. et al. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14, 71–84 (2005).
  CAS PubMed Google Scholar
• Tang, B. et al. Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum. Mol. Genet. 15, 1816–1825 (2006).
  CAS PubMed Google Scholar
• Canet-Aviles, R. M. et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl Acad. Sci. USA 101, 9103–9108 (2004).
  ADS CAS PubMed PubMed Central Google Scholar
• Yang, Y. et al. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl Acad. Sci. USA 102, 13670–13675 (2005).
  ADS CAS PubMed PubMed Central Google Scholar
• Kim, R. H. et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7, 263–273 (2005).
  CAS PubMed Google Scholar
• Kim, R. H. et al. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl Acad. Sci. USA 102, 5215–5220 (2005).
  ADS CAS PubMed PubMed Central Google Scholar
• Meulener, M. C., Xu, K., Thompson, L., Ischiropoulos, H. & Bonini, N. M. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc. Natl Acad. Sci. USA 103, 12517–12522 (2006).
  ADS CAS PubMed PubMed Central Google Scholar
• Valente, E. M. et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158–1160 (2004).
  ADS CAS PubMed Google Scholar
• Silvestri, L. et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet. 14, 3477–3492 (2005).
  CAS PubMed Google Scholar
• Petit, A. et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280, 34025–34032 (2005).
  CAS PubMed Google Scholar
• Yang, Y. et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl Acad. Sci. USA 103, 10793–10798 (2006).
  ADS CAS PubMed PubMed Central Google Scholar
• West, A. B. et al. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl Acad. Sci. USA 102, 16842–16847 (2005).
  ADS CAS PubMed PubMed Central Google Scholar
• Strauss, K. M. et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099–2111 (2005).
  CAS PubMed Google Scholar
• Martins, L. M. et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 24, 9848–9862 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mattiazzi, M. et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277, 29626–29633 (2002).
  CAS PubMed Google Scholar
• Damiano, M. et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J. Neurochem. 96, 1349–1361 (2006).
  CAS PubMed Google Scholar
• Kong, J. & Xu, Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 18, 3241–3250 (1998).
  CAS PubMed PubMed Central Google Scholar
• Jaarsma, D. et al. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. (Berl.) 102, 293–305 (2001).
  CAS Google Scholar
• Higgins, C. M., Jung, C. & Xu, Z. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 4, 16 (2003).
  PubMed PubMed Central Google Scholar
• Vijayvergiya, C., Beal, M. F., Buck, J. & Manfredi, G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci. 25, 2463–2470 (2005).
  CAS PubMed PubMed Central Google Scholar
• Liu, J. et al. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43, 5–17 (2004).
  CAS PubMed Google Scholar
• Takeuchi, H., Kobayashi, Y., Ishigaki, S., Doyu, M. & Sobue, G. Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 277, 50966–50972 (2002).
  CAS PubMed Google Scholar
• Okado-Matsumoto, A. & Fridovich, I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc. Natl Acad. Sci. USA 99, 9010–9014 (2002).
  ADS CAS PubMed PubMed Central Google Scholar
• Pasinelli, P. et al. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43, 19–30 (2004).
  CAS PubMed Google Scholar
• Jenkins, B. G., Koroshetz, W. J., Beal, M. F. & Rosen, B. R. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 43, 2689–2695 (1993).
  CAS PubMed Google Scholar
• Gu, M. et al. Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385–389 (1996).
  CAS PubMed Google Scholar
• Milakovic, T. & Johnson, G. V. Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J. Biol. Chem. 280, 30773–30782 (2005).
  CAS PubMed Google Scholar
• Brouillet, E. et al. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl Acad. Sci. USA 92, 7105–7109 (1995).
  ADS CAS PubMed PubMed Central Google Scholar
• Benchoua, A. et al. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol. Biol. Cell 17, 1652–1663 (2006).
  CAS PubMed PubMed Central Google Scholar
• Panov, A. V. et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nature Neurosci. 5, 731–736 (2002).
  CAS PubMed Google Scholar
• Choo, Y. S., Johnson, G. V., MacDonald, M., Detloff, P. J. & Lesort, M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13, 1407–1420 (2004).
  CAS PubMed Google Scholar
• Luthi-Carter, R. & Cha, J.-H. J. Mechanisms of transcription dysregulation in Huntington's disease. Clin. Neurosci. Res. 3, 165–177 (2003).
  CAS Google Scholar
• Sugars, K. L. & Rubinsztein, D. C. Transcriptional abnormalities in Huntington disease. Trends Genet. 19, 233–238 (2003).
  CAS PubMed Google Scholar
• Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W. & Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell 7, 673–682 (2001).
  CAS PubMed Google Scholar
• Chipuk, J. E. et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010–1014 (2004).
  ADS CAS PubMed Google Scholar
• Bae, B. I. et al. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47, 29–41 (2005).
  CAS PubMed Google Scholar
• Lin, J. et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 119, 121–135 (2004).
  CAS PubMed Google Scholar
• Rathke-Hartlieb, S. et al. Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2. Exp. Neurol. 175, 87–97 (2002).
  CAS PubMed Google Scholar